Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Trial Profile

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2018

At a glance

  • Drugs Methylphenidate (Primary) ; Mixed amfetamine salts (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2018 Status changed from not yet recruiting to recruiting.
    • 08 Mar 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
    • 08 Mar 2018 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top